1+ months

Director, Global Health Economics Outcomes Research - Oncology and Biosimilars

Parsippany, NJ 07054
Company Info
Teva is a global pharmaceutical leader and the world's largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we've built a promising pipeline centered around our core therapeutic areas. We are continually developing patient-centric solutions and significantly growing both our generic and specialty medicines business through investment in research and development, marketing, business development and innovation. This is how we improve health and enable people to live better, healthier lives. Join us on our journey of growth!
Job Description

The Director, Global Health Economics & Outcomes Research (GHEOR) position functions within the Global HEOR group and will serve as the principal technical and strategic lead for one or more assets in the Oncology and Biosimilars therapy areas. The position will report to the Senior Director, Late Stage Global HEOR.

  • In accordance with Tevas regulatory and governance requirements, develop and implement peri- and post-launch comprehensive evidence generation plans, including clinical, economic, and humanistic evidence that inform and contribute to the overall program strategies for one or more assets in the oncology/biosimilars therapy area.
  • Incorporate, where possible, and in close collaboration with regional HEOR colleagues, regional post-launch evidence needs through regular communication and collaboration with individual regional medical colleagues e.g. Medical Outcomes Liaison (MOL) and Medical Science Liaison (MSL),and other global functions, e.g. brand teams, medical and EU/US/IM market access.
  • Working closely with relevant cross-functional colleagues, develop and update global and AMCP dossiers as well as relevant economic models, to appropriately support biosimilar asset launch(es).
  • Lead the execution of post-launch RWE studies to maximize asset value proposition in collaboration with medical affairs and in consultation with other cross-functional colleagues. These studies may include longitudinal prospective observational studies, registries, retrospective database analyses, chart reviews, patient/HCP/caregiver surveys, etc. Obtain necessary medical affairs approvals for these RWE studies and collaborate with the appropriate colleagues to execute studies.
  • Contribute to the payer value and brand team(s) on specific ways in which the evidence generation plan may be improved and optimized to facilitate informed decision making including comparative effectiveness, pricing, reimbursement and market access negotiations, in compliance with regional regulations for use in promotional material. 
  • Represent Teva before relevant scientific, medical, regulatory, payer, patient and other meetings.
  • Explore, obtain approvals for, and implement new concepts that are complex, taking appropriate risks to advance innovative processes and methodologies based on comprehensive business knowledge, e.g. value-based contracts, employer research, etc.
Job Description, continued
  • Keep abreast of the trends in the oncology/biosimilars therapeutic area, Global HEOR, Pricing, Reimbursement, and Market Access across key regions (US, EU, and international markets), and proactively address GHEOR strategy changes in collaboration with global and regional teams in anticipation of these trends.
  • Build a network of clinical, HEOR and payer experts, including academics, policy makers, HTA representatives, reimbursement influencers and other decision-makers globally to increase the robustness of post-marketing scientific studies in support of market access strategies.
  • Manage project budgets and timelines in adherence with Teva compliance requirements. To this end, regularly prepare and update tracking tools and departmental share point site reflecting ongoing or completed deliverables and annual planning documents.
  • Collaborate with scientific communications to provide HEOR input on scientific platform and develop HEOR-related scientific publications to be presented at key medical and HEOR/payer conferences, publications, dossiers, and other channels as appropriate.
  • Collaborate closely and align with Development HEOR colleagues and in a cross-functional matrix team environment and effectively design, execute, and effectively communicate relevant GHEOR study results to internal and external audiences. 
  • PhD in Health Economics, Epidemiology, Health Services Research or a related field with at least 7 years of relevant pharmaceutical/biotechnology/academic/governmental agency experience


  • Master's degree in Health Economics, Epidemiology, or related field, and at least 10 years of such relevant experience.  A pharmacy/clinical/scientific background is preferred


Experience Required:   

  • Ability to quickly learn the evidence needs within the oncology/biosimilars therapy area and support the HEOR strategy and tactics execution with minimal supervision
  • Experience in application of HEOR strategies and tactics for products near to or close to launch, or that are marketed. 
  • Track record of peer-reviewed scientific publications demonstrating expertise in GHEOR
  • Comprehensive knowledge of HEOR and good working knowledge of health care systems and health technology assessment guidelines and processes in relevant countries.
  • Serve as source of expertise/advice in epidemiology, outcomes research, health economics, health policy for cross-functional team members.

Experience Preferred:  

  • Experience in oncology/biosimilars  therapy area would be a plus.
  • Experience with global HTA submissions and/or value frameworks is preferred.
Medical Affairs
Sub Function
Health Economics
Reports To

Senior Director, Late Stage Global HEOR (Health Economics & Outcomes Research)

Tevas Equal Employment Opportunity Commitment
Teva Pharmaceuticals is committed to equal opportunity in employment. It is Teva's global policy that equal employment opportunity be provided without regard to age, race, creed, color, religion, sex, disability, pregnancy, medical condition, sexual orientation, gender identity or expression, ancestry, veteran status, national or ethnic origin or any other legally recognized status entitled to protection under applicable laws.


Posted: 2019-12-12 Expires: 2020-01-24

Join us at the forefront of pharmaceutical research and production. With state-of-the-art facilities, highly skilled colleagues, and a high-powered organizational culture, Teva offers you countless possibilities to make a real difference in people's lives and add value to your career.

Before you go...

Our free job seeker tools include alerts for new jobs, saving your favorites, optimized job matching, and more! Just enter your email below.

Share this job:

Director, Global Health Economics Outcomes Research - Oncology and Biosimilars

Teva Pharmaceuticals
Parsippany, NJ 07054

Join us to start saving your Favorite Jobs!

Sign In Create Account
Powered ByCareerCast